Adrenergic Neurons: Neurotransmission

Noradrenaline synthesis begins when tyrosine enters the neuronal cytoplasm via sodium-dependent carrier transport. Tyrosine hydroxylase catalyzes the rate-limiting conversion of tyrosine to DOPA, which is then decarboxylated to dopamine. Dopamine β-hydroxylase converts dopamine to noradrenaline, which is stored in synaptic vesicles for later release.

Arrival of a neuronal action potential causes calcium ions to influx into the neuronal cytoplasm. This calcium influx triggers vesicular exocytosis, rupturing synaptic vesicles and releasing noradrenaline into the synaptic junction. The released noradrenaline then binds to adrenergic receptors on nerve endings or effector organs.

Noradrenaline action is terminated through three mechanisms: neuronal reuptake via the noradrenaline transporter, extraneuronal uptake by nearby cells, or diffusion into systemic circulation. Post-reuptake, noradrenaline is either stored in synaptic vesicles or oxidized by monoamine oxidase (MAO). This recycling and metabolism prevents prolonged receptor activation.

Catecholamines are neurotransmitters including noradrenaline, dopamine, adrenaline, and epinephrine, characterized by a catechol moiety and amine side chain. In adrenergic neurons, noradrenaline serves as the principal neurotransmitter released by postganglionic sympathetic fibers. These molecules activate adrenergic receptors to produce the fight-or-flight response.

Synthesized noradrenaline is transported from the cytoplasm into synaptic vesicles via the vesicular monoamine transporter (VMAT). This active transport concentrates noradrenaline within vesicles, protecting it from degradation and preparing it for rapid release upon neuronal stimulation. Storage in vesicles maintains the neuron's readiness to respond to action potentials.

Catecholamines are metabolized by two primary enzymes: monoamine oxidase (MAO) converts catecholamines to aldehydes, which are further metabolized to carboxylic acids, while catechol-O-methyltransferase (COMT) methylates catechol hydroxyl groups. The final product, 3-methoxy-4-hydroxyphenylglycol (MHPG), undergoes partial conjugation before urinary excretion as glucuronide or sulfate derivatives.

Dopamine is an intermediate in noradrenaline synthesis; dopamine β-hydroxylase converts dopamine to noradrenaline in synaptic vesicles. Released noradrenaline binds to adrenergic receptors, triggering cellular cascades and second messenger formation that transduce the signal into physiological effects. Understanding this pathway is essential for studying adrenergic agonists and their mechanisms.